Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 12/20 | 0.77 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.60 |
| ▸ | FAAH | O00519 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.54 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.51 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3751271 | 1.00 | NOD1 (0.77) | NOD1SLC6A5FAAHMEN1KMT2A | |
| SCHEMBL17941648 | 1.00 | NOD1 (0.77) | NOD1SLC6A5FAAHMEN1KMT2A | |
| SCHEMBL6579626 | 1.00 | NOD1 (0.77) | NOD1SLC6A5FAAHMEN1KMT2A | |
| SCHEMBL131586 | 1.00 | NOD1 (0.77) | NOD1SLC6A5FAAHMEN1KMT2A | |
| SCHEMBL9829340 | 1.00 | NOD1 (0.77) | NOD1SLC6A5FAAHMEN1KMT2A | |
| SCHEMBL22996019 | 1.00 | NOD1 (0.77) | NOD1SLC6A5FAAHMEN1KMT2A | |
| SCHEMBL17941649 | 1.00 | NOD1 (0.77) | NOD1SLC6A5FAAHMEN1KMT2A | |
| SCHEMBL9829330 | 1.00 | NOD1 (0.77) | NOD1SLC6A5FAAHMEN1KMT2A | |
| SCHEMBL5122358 | 1.00 | NOD1 (0.77) | NOD1SLC6A5FAAHMEN1KMT2A | |
| SCHEMBL5888062 | 1.00 | NOD1 (0.77) | NOD1SLC6A5FAAHMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1730197-B1 | METHODS FOR INDUCING AUTOLYSIS IN INFECTIOUS BACTERIA | HAPTOGEN LTD (GB) | 2012-03-07 | — | — | EP | claimed |
| CN-110023251-B | Biological bead for biofouling control in membrane bioreactors | 南洋理工大学 | 2022-03-11 | — | — | CN | disclosed |
| US-8932807-B2 | High throughput in vitro translation (cell-lysate based) assay for detecting quorum sensing signals | UNIVERSITY OF SOUTH CAROLINA (US) | 2015-01-13 | — | — | US | disclosed |
| US-20140030750-A1 | High Throughput In Vitro Translation (Cell-Lysate Based) Assay for Detecting Quorum Sensing Signals | DECHO ALAN W (US) | 2014-01-30 | — | — | US | disclosed |
| US-8546071-B2 | High-throughput in vitro translation (cell-lysate based) assay for detecting quorum sensing signals | UNIVERSITY OF SOUTH CAROLINA (US) | 2013-10-01 | — | — | US | disclosed |
| US-20120164672-A1 | HIGH-THROUGHPUT IN VITRO TRANSLATION (CELL-LYSATE BASED) ASSAY FOR DETECTING QUORUM SENSING SIGNALS | UNIVERSITY OF SOUTH CAROLINA (US) | 2012-06-28 | — | — | US | disclosed |
| US-20100291566-A1 | SYSTEMS AND METHODS FOR DIAGNOSIS AND MONITORING OF BACTERIA-RELATED CONDITIONS | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION | 2010-11-18 | — | — | US | disclosed |
| WO-2009036081-A1 | SYSTEMS AND METHODS FOR DIAGNOSIS AND MONITORING OF BACTERIA-RELATED CONDITIONS | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2009-03-19 | — | — | WO | disclosed |
| US-7442798-B2 | Quinone-indicator antibiotics, particularly2-heptyl-3-hydroxy-4-quinolone, and analogs; regulating the expression of a bacterial gene; modulating bacteria quorum sensing signaling | THE UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2008-10-28 | — | — | US | disclosed |
| US-20050227345-A1 | Quorum sensing signaling in bacteria | AURORA BIOSCIENCES CORPORATION (US) | 2005-10-13 | — | — | US | disclosed |
| US-6855513-B1 | Quorum sensing signaling in bacteria | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2005-02-15 | — | — | US | disclosed |
| US-20050009869-A1 | Novel autoinducer molecules and uses therefor | NATIONAL SCIENCE FOUNDATION | 2005-01-13 | — | — | US | disclosed |
| US-6723321-B2 | MODULATION OF LYASE ACTIVITY; OBTAIN SAMPLE CONTAINING LYASE, INCUBATE WITH SUBSTRATE AND MODULATOR, MONITOR ADJUSTMENT IN BINDING OF SUBSTRATE TO LYASE, ADJUSTMENT IN BINDING INDICATES MODULATOR | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS | 2004-04-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050227345-A1 | Quorum sensing signaling in bacteria | PGLS, Q6ZSR9, FDPS | NOD1 1892/4885SLC6A5 2123/4885FAAH 1802/4885 |
| US-20050009869-A1 | Novel autoinducer molecules and uses therefor | QARS1, PGLS, SQLE | NOD1 272/4885SLC6A5 3212/4885FAAH 1450/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.